文献速递糖尿病

电子病患者概览与警示系统可提高2型糖尿病患者的降脂药处方率

Use of electronic patient data overview with alerts in primary care increases prescribing of lipid-lowering medications in patients with type 2 diabetes.
PubMed 文献 · Diabetologia · 2021-10-28

该观察性研究纳入2012年高度使用电子疾病管理程序(DMP)的165名全科医生和2013年才高度使用DMP的135名全科医生作为对照,评估DMP群体概览及未处方警示对无降脂治疗史的2型糖尿病患者降脂药处方的影响。结果显示,使用DMP的全科医生患者接受降脂药处方的比值比显著更高(OR 1.23 [95% CI 1.09, 1.38]),且亚组分析显示增加主要见于男性、60-70岁、糖尿病病程≤5年、非贫困及无合并症患者。

要点

  • DMP群体概览与警示可提高无降脂治疗史2型糖尿病患者的降脂药处方率。
  • 处方增加主要见于男性、60-70岁、病程≤5年、非贫困及无合并症患者。
  • 安慰剂测试未发现选择偏倚,结果稳健。

核心结论

  • 使用带有未处方警示的DMP群体概览可增加全科医生对2型糖尿病患者降脂药的处方。

研究设计与样本

  • 观察性研究,纳入165名2012年高度使用DMP的全科医生和135名2013年才高度使用DMP的对照全科医生。
  • 研究对象为研究期前一年(2011年)未接受降脂药处方的2型糖尿病患者,评估12个月暴露期内是否处方并配取降脂药。
  • 采用多变量逻辑回归分析计算OR,并进行亚组分层和安慰剂测试。

主要发现

  • 与对照全科医生相比,使用DMP的全科医生患者接受降脂药处方的OR为1.23(95% CI 1.09, 1.38)。
  • 男性亚组OR为1.32(95% CI 1.12, 1.54),60-70岁亚组OR为1.40(95% CI 1.13, 1.74)。
  • 糖尿病病程≤5年亚组OR为1.33(95% CI 1.13, 1.56),非贫困亚组OR为1.25(95% CI 1.08, 1.45)。
  • 无合并症(CCI评分=0)亚组OR为1.27(95% CI 1.11, 1.45)。
  • 将分析期提前2年的安慰剂测试未发现两组降脂药处方存在显著差异。

临床怎么用

  • 在初级保健中,可考虑使用带有临床性能警示的电子疾病管理程序群体概览,以促进指南推荐的降脂药处方。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: We aimed to assess whether general practices (GPs) using an electronic disease management program (DMP) with population overviews, including alerts when patients failed to receive guideline-recommended prescription medications, increased prescriptions of lipid-lowering drugs for patients with type 2 diabetes with no history of lipid-lowering treatment. METHODS: This observational study included 165 GPs that reached a high level of use of the DMP in 2012 and a control group of 135 GPs who reached a high level of use in 2013 and, hence, who were less exposed to the DMP throughout 2012. A binary measure for having been prescribed and filled lipid-lowering drugs at any time within a 12-month exposure period was derived for all patients with type 2 diabetes who did not receive a prescription for lipid-lowering drugs in the baseline year prior to the study period (i.e. 2011). Results were derived using ORs from multivariate logistic regression analyses. Subgroup stratification based on age, sex, diabetes duration, deprivation status and Charlson Comorbidity Index (CCI) score was conducted and assessed. Placebo tests were carried out to assess bias from selection to treatment. RESULTS: Patients who did not receive a prescription of lipid-lowering drugs in the year prior to being listed with GPs that used the DMP had statistically significant greater odds of receiving a prescription of lipid-lowering medications when compared with individuals who attended control GPs (OR 1.23 [95% CI 1.09, 1.38]). When the analysis period was shifted back by 2 years, no significant differences in lipid-lowering drug prescription between the two groups were found to occur, which indicates that these results were not driven by selection bias. Subgroup analyses showed that the increase in lipid-lowering drug prescriptions was primarily driven by changes among male participants (OR 1.32 [95% CI 1.12, 1.54]), patients aged 60-70 years (OR 1.40 [95% CI 1.13, 1.74]), patients with a diabetes duration of ≤5 years (OR 1.33 [95% CI 1.13, 1.56]), non-deprived patients (OR 1.25 [95% CI 1.08, 1.45]) and patients without comorbidities (CCI score = 0; OR 1.27 [95% CI 1.11, 1.45]). CONCLUSIONS/INTERPRETATION: Access to population overviews using a DMP with alerts of clinical performance measures with regard to adhering to guideline-recommended prescription of medications can increase GP prescriptions of lipid-lowering drugs.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Charles MH, Thomsen JL, Christensen B, et al. Use of electronic patient data overview with alerts in primary care increases prescribing of lipid-lowering medications in patients with type 2 diabetes. Diabetologia. 2021. PMID: 34709425. doi:10.1007/s00125-021-05598-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。